.

A Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies
1 June 2022
By Mark Laurie

This poster, created in collaboration with Bristol Myers Squibb, details OracleBio’s robust image analysis workflow in Indica Labs HALO, and how it helped overcome common technical issues encountered in a large multiplex IF (mIF) non-small cell lung cancer (NSCLC) study.

The poster, ‘Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies‘, was presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York.

Click the thumbnail image below to view or download the high-resolution poster PDF:

Multiplex Digital Phenotyping of the Tumour Microenvironment AACR 2021

More from OracleBio:

MedImmune Poster Presentation, European Respiratory Society 2016

MedImmune Poster Presentation, European Respiratory Society 2016

OracleBio were delighted to present a poster at the Eropean Respiratory Society (ERS) Conference, London, Sept, 2016. The poster, entitled ‘Tryptase+ mast cells associate with fibrotic regions in the lungs of idiopathic pulmonary fibrosis patients; a multiplex...

Learn More About OracleBio's Multiplex IF Analysis

Explore OracleBio's Scientific Posters

Stay up to date with OracleBio

Sign up to our mailing list to stay informed about news, webinars, events and more